KRYS
Krystal Biotech Inc.
$302.68
+$3.23(+1.08%)
62
Overall
65
Value
63
Tech
60
Quality
Market Cap
$5.74B
Volume
181.91K
52W Range
$123.03 - $319.48
Target Price
$330.20
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | -- | -- | -- | -- | -- | $50.7M | $290.5M | $389.1M | ||
| Total Revenue | -- | -- | -- | -- | -- | $50.7M | $290.5M | $389.1M | ||
| COST OF GOODS SOLD | ||||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | $3.1M | $20.1M | -- | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | -- | -- | -- | -- | -- | $50.7M | $290.5M | $389.1M | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $-4.8M | $-22.1M | $33.0M | $68.3M | $120.2M | $160.4M | $224.8M | $227.8M | ||
| Research & Development | $3.2M | $15.6M | $17.9M | $27.9M | $42.5M | $46.4M | $53.6M | $58.0M | ||
| Research Expense | $3.2M | $15.6M | $17.9M | $27.9M | $42.5M | $46.4M | $53.6M | $58.0M | ||
| Selling, General & Administrative | $1.6M | $6.5M | $15.1M | $40.4M | $77.7M | $98.4M | $113.6M | $146.7M | ||
| General & Administrative Expenses | $1.6M | $6.5M | $15.1M | $40.4M | $77.7M | $98.4M | $113.6M | $146.7M | ||
| Salaries & Wages | $-246.0K | $-1.2M | $34.0K | $284.0K | $31.4M | -- | -- | -- | ||
| Depreciation & Amortization | $-23.0K | $-748.0K | $1.5M | $1.8M | $2.6M | $5.0M | $6.0M | -- | ||
| Depreciation & Amortization | $-23.0K | $-748.0K | $1.5M | $1.8M | $2.6M | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | $767.0K | $1.4M | $1.8M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||
| Operating income | $-4.8M | $-22.1M | $-33.0M | $-68.3M | $-145.2M | $-109.7M | $65.7M | $161.3M | ||
| EBITDA | $-7.9M | $-21.0M | $-30.3M | $-66.2M | $-146.4M | $-3.8M | $72.5M | $167.8M | ||
| NON-OPERATING ITEMS | ||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $1.5M | -- | $-22.6M | $-29.6M | $-28.2M | ||
| Intinc | $-3.1M | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-3.1M | -- | -- | $-1.5M | $-5.2M | $22.6M | $29.6M | $28.2M | ||
| Other Income/Expense | -- | -- | -- | -- | $-25.0M | $-100.0M | $21.5M | -- | ||
| Other Special Charges | -- | -- | -- | -- | -- | $100.0M | -- | -- | ||
| SPECIAL ITEMS | ||||||||||
| Special Income Charges | -- | -- | -- | $560.0K | $-25.0M | $-12.5M | $-37.5M | -- | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $-7.9M | $-22.1M | $-32.2M | $-68.1M | $-150.4M | $-9.7M | $65.7M | $161.3M | ||
| Pre-Tax Income | $-7.9M | $-22.1M | $-33.0M | $-69.8M | $-140.0M | $12.9M | $95.4M | $189.5M | ||
| INCOME TAX | ||||||||||
| Tax Provision | $-1.0M | -- | $-2.6M | $-5.4M | $-10.4M | $2.0M | $6.2M | $-15.4M | ||
| NET INCOME | ||||||||||
| Net Income | $-7.9M | $-19.1M | $-32.2M | $-69.6M | $-140.0M | $10.9M | $89.2M | $204.8M | ||
| Net Income (Continuing Operations) | $-7.9M | $-19.1M | $-32.2M | $-69.6M | $-140.0M | $10.9M | $89.2M | $204.8M | ||
| Net Income (Discontinued Operations) | $-7.9M | $-19.1M | $-32.2M | $-69.6M | $-140.0M | $10.9M | $89.2M | $204.8M | ||
| Net Income (Common Stockholders) | $-7.9M | $-19.1M | $-32.2M | $-69.6M | $-140.0M | $10.9M | $89.2M | $204.8M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | $174.1M | ||
| TOTALS | ||||||||||
| Total Expenses | $-4.8M | $-22.1M | $33.0M | $68.3M | $120.2M | $160.4M | $224.8M | $227.8M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $5.4M | $15.9M | $18.8M | $22.2M | $25.5M | $27.2M | $28.6M | $28.9M | ||
| Average Shares Outstanding (Diluted) | $5.4M | $15.9M | -- | $22.2M | $25.5M | $27.8M | $29.7M | $30.0M | ||
| Shares Outstanding | $10.3M | $17.4M | $22.2M | $25.2M | $25.8M | $28.3M | $28.8M | $29.2M | ||
| Basic EPS | -- | -- | $-1.71 | $-3.13 | $-5.49 | $0.40 | $3.12 | $7.08 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-1.71 | $-3.13 | $-5.49 | $0.40 | $3.12 | $7.08 | ||
| Diluted EPS | $-1.48 | $-1.2 | $-1.71 | $-3.13 | $-5.49 | $0.39 | $3 | $6.84 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-3.13 | $-5.49 | $0.39 | $3 | $6.84 | ||
| OTHER METRICS | ||||||||||
| Net Income From Other Gains Losses | -- | $3.0M | $832.0K | $197.0K | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | $-560.0K | $25.0M | $12.5M | $37.5M | -- | ||
| Other Gand A | $1.6M | $6.5M | $15.1M | $40.4M | $77.7M | $98.4M | $113.6M | $146.7M | ||
| Rent And Landing Fees | $1.6M | $6.5M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRYS | $302.68 | +1.1% | 181.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |